Orchestra BioMed Holdings, Inc. Annual Cost of Revenue in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Orchestra BioMed Holdings, Inc. quarterly/annual Cost of Revenue history and growth rate from 2022 to 2023.
  • Orchestra BioMed Holdings, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $68K, a 65.9% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $193K, a 0.52% increase year-over-year.
  • Orchestra BioMed Holdings, Inc. annual Cost of Revenue for 2023 was $186K, a 11.8% decline from 2022.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $186K -$25K -11.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $211K Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.